Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT00002433
Eligibility Criteria:
Inclusion Criteria
Patients must have:
* Diagnosis of AIDS with one or more opportunistic infections.
* Kaposi's sarcoma with prior history of opportunistic infection.
* Stable dose of zidovudine (AZT) therapy.
* Preserved pulmonary, renal and hepatic function.
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
* Presence of active infection.
* Active opportunistic infections.
* Cardiac disease.
* Central nervous system disorders.
* History of seizures.
* Irreversible airway disease.
Patients with the following are excluded:
* Co-existing conditions and symptoms listed in Patient Exclusion Co-existing Conditions.
Prior Medication:
Excluded within 4 weeks of study entry:
* Immunosuppressive therapy.
* Cytotoxic therapy.
* Excluded:
* Interferon gamma therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00002433
Study Brief:
Protocol Section:
NCT00002433